glp-1 oral tablets Weight-Loss Pill Study Compares Effectiveness to Injectables New GLP-1 pill helps patients

Biosimilar development is beginning, though patent protection will sustain originator pricing through much of the forecast period

We wanted to offer something different: clear pricing, real clinical oversight, and direct access without the runaround. - Lucas Reynolds, CEO and Founder of Kongo

Amazon has been circling the healthcare space for years

Why refrigeration matters for GLP-1 peptides GLP-1 receptor agonists are peptide-based medications

Tirzepatide was approved by the FDA for the treatment of diabetes in May 2022 and a few months later in the European Union, Canada and Australia

Studies and regulatory findings include: In June 2025, the World Health Organization alerted healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with semaglutide medications, including Ozempic, Rybelsus, and Wegovy